Weltzin MM , George AA , Lukas RJ , Whiteaker P .

P20 GM103395 NIGMS NIH HHS , R01 DA043567 NIDA NIH HHS

                epilepsy

	Fig 1. Unitary amplitudes associated with human HS- and LS-isoform α4(R336H)β2-nAChR expressed in Xenopus laevis oocytes.Example single-channel ACh evoked response traces are shown below panels (A), (B), and (C), exhibiting a typical mixture of individual openings and short bursts of activity, interspersed with longer periods of inactivity. (A) Amplitudes of HS-isoform α4(R336H)β2-nAChR open events evoked by 1.3 μM ACh are characterized as a single population. (B and C) LS-isoform α4(R336H)β2-nAChR single-channel openings appeared to exhibit two distinct amplitudes, whether they were evoked in the presence of either a low ACh concentration (0.7 μM; Panel B) or a high ACh concentration (30 μM; Panel C). This finding was confirmed by two-way ANOVA, using ACh concentration and apparent amplitude class (small opening (OS) or large opening (OL)) as factors. A main effect of amplitude class was observed, confirming that amplitudes of OS and OL are distinctly different from each other (F1,22 = 144.7, ɫɫɫɫP < 0.0001). In contrast, no main effect of ACh concentration on open amplitude was observed (F1,22 = 0.04, P = 0.53), nor was there a significant interaction between the two factors (interaction ACh concentration x amplitude size F1,22 = 0.25, P = 0.25). Accordingly, the amplitudes of OS and large opening OL were not significantly altered by changes in the concentration of ACh applied. Amplitude histograms represent events collected across multiple individual single-channel patch recordings, for each illustrated combination of receptor construct and ACh concentration. Values are given as mean ± S.E.M., and were collected from 5–8 patches across a minimum of three separate experiments.
	Fig 2. Unitary amplitudes associated with human HS- and LS-isoform α4β2(V337G)-nAChR expressed in Xenopus laevis oocytes.As in Fig 1, example single-channel ACh evoked response traces are shown below panels (A), (B), and (C), which display a mixture of individual openings and short bursts of activity, which are interspersed with longer periods of inactivity. (A) HS-isoform α4β2(V337G)-nAChR stimulated with 1.3 μM ACh produced single-channel openings with a single characteristic amplitude. (A) Amplitudes of HS-isoform α4(R336H)β2-nAChR open events evoked by 1.3 μM ACh are characterized as a single population. (B and C) LS-isoform α4β2(V337G)-nAChR single-channel openings appeared to exhibit two distinct amplitudes, whether they were evoked in the presence of either a low ACh concentration (0.7 μM; Panel B) or a high ACh concentration (30 μM; Panel C). Similar to the findings for LS-isoform α4(R336H)β2-nAChR, this was confirmed by two-way ANOVA. A main effect of amplitude class was again observed, confirming that amplitudes of small openings (OS) and large openings (OL) are distinctly different from each other (F1,20 = 124.2, ɫɫɫɫP < 0.0001). In a further point of similarity with LS-isoform α4(R336H)β2-nAChR, the amplitudes of OS and OL of LS-isoform α4β2(V337G)-nAChR were not significantly altered by changes of applied ACh concentration (F1,22 = 0.04, P = 0.53), nor was there a significant interaction between the two factors (interaction ACh concentration x amplitude size F1,22 = 0.25, P = 0.25). Amplitude histograms represent events collected across multiple individual single-channel patch recordings, for each illustrated combination of receptor construct and ACh concentration. Values are given as mean ± S.E.M, and were collected from 5–7 patches across a minimum of three separate experiments.
	Fig 3. Closed-dwell time durations between single-channel openings of human HS- or LS-isoform α4(R336H)β2- or α4β2(V337G)-nAChR isoforms expressed in Xenopus laevis oocytes.(A) HS-isoform α4(R336H)β2-nAChR were stimulated with ACh (1.3 μM) and the resulting closed-dwell time durations between openings were best described with a pair of time constants. (B) When LS-isoform α4(R336H)β2-nAChR were stimulated at a low ACh concentration (0.7 μM), closed durations between openings were best described with three time constants. (C) The number of time constants required to best fit closed time distributions did not change as LS-isoform α4(R336H)β2-nAChR were stimulated at a higher ACh concentration (30 μM). (D) HS-isoform α4β2(V337G)-nAChR were stimulated with ACh (1.3 μM) and the resulting closed durations between openings were best described with a pair of time constants. (E) When LS-isoform α4β2(V337G)-nAChR were stimulated with a low ACh concentration (0.7 μM), closed durations between openings were best described with three time constants. (F) Increasing the ACh concentration to 30 μM did not change the number of time constants required to best fit closed duration distributions of LS-isoform α4β2(V337G)-nAChR. Closed-dwell duration histograms are representative examples collected from individual single-channel patch recordings. Individual τ values and percentage of total events corresponding to each closed duration (in parentheses) from these example patch recordings have been inserted into each panel to facilitate interpretation. Data were collected from 5–8 individual patches, across at least three separate experiments. Mean values of each property calculated from group data are summarized in Table 3, as mean ± SEM, together with any statistical analyses applied.
	Fig 4. Open-dwell time durations observed for HS- or LS-isoform human α4(R336H)β2- and α4β2(V337G)-nAChR expressed in Xenopus laevis oocytes.(A) Stimulation of HS-isoform α4(R336H)β2-nAChR with ACh (1.3 μM) resulted in open- dwell-time durations best described with a pair of time constants. (B) Simulation of LS-isoform α4(R336H)β2-nAChR at a low ACh concentration (0.7 μM) also resulted in open durations that were best fit using two time constants. (C) The number of time constants required to best fit the open time distributions did not change as LS-isoform α4(R336H)β2-nAChR were stimulated at a higher ACh concentration (30 μM). (D) Simulation of HS-isoform α4β2(V337G)-nAChR with ACh (1.3 μM) resulted in open durations again best described with a pair of time constants. (E) When LS-isoform α4β2(V337G)-nAChR were stimulated with a low ACh concentration (0.7 μM), open-dwell times were also best fit using two time constants. (F) Increasing the ACh concentration to 30 μM did not change the number of time constants required to best fit the open duration distribution of LS-isoform α4β2(V337G)-nAChR. Open-dwell time histograms are representative examples resulting from analysis of individual single-channel patch recordings. Individual τ values and percentage of total events (in parentheses) corresponding to each open duration from these example patch recordings have been inserted into each panel to facilitate interpretation. Data were collected from 5–8 individual patches, across at least three separate experiments. Mean values of each property calculated from group data are summarized in Table 4, as mean ± SEM, together with any statistical analyses applied.
	Fig 5. Closed-dwell time durations between burst activity of human LS-isoform α4(R336H)β2-nAChR.Closed-dwell time durations between bursts of activity (interburst durations) were measured for LS-isoform α4(R336H)β2-nAChR expressed in Xenopus laevis oocytes. Closed durations between bursts of either small (A) or large amplitude (A’) events evoked from LS-isoform α4(R336H)β2-nAChR at a low ACh concentration (0.7 μM) were best fit with four or three τ values, respectively. Increasing the ACh concentration to 30 μM resulted in LS-isoform α4(R336H)β2-nAChR closed state intervals between bursts of small (B) or large amplitude (B’) events that were best fit with five and four time constants, respectively. Interburst duration histograms are shown for pooled data from all recordings, which result from collection of data from 5 or 8 individual patches, across at least three separate experiments. The calculated τ values are summarized as mean ± SEM in Table 5, together with the statistical analyses applied.
	Fig 6. Closed-dwell time durations between burst activity of human LS-isoform α4β2(V337G)-nAChR.Closed-dwell time durations between bursts of activity (interburst closed durations) were measured for LS-isoform α4β2(V337G)-nAChR expressed in Xenopus laevis oocytes. Closed durations between bursts of either small (A) or large amplitude (A’) events evoked from LS-isoform α4β2(V337G)-nAChR at a low ACh concentration (0.7 μM) were best fit with either three or four τ values, respectively. Increasing the ACh concentration to 30 μM resulted in closed state intervals between bursts of LS-isoform α4β2(V337G)-nAChR small (B) or large amplitude (B’) events that were best fit with four and three time constants, respectively. Interburst closed duration histograms are shown for pooled data from all recordings, which result from collection of data from 5 or 7 individual patches, across at least three separate experiments. The calculated τ values are summarized as mean ± SEM in Table 5, together with the statistical analyses applied.
	Fig 7. Durations of individual openings within bursts of small or large amplitude openings of human LS-isoform α4(R336H)β2-nAChR.LS-isoform α4(R336H)β2-nAChR were expressed in Xenopus laevis oocytes and durations of individual openings within bursts of activity (intraburst openings) were measured. For LS-isoform α4(R336H)β2-nAChR stimulated with a low ACh concentration (0.7 μM), bursts of either small (A) or large amplitude (A’) events were seen. Openings within bursts of small amplitude events were best characterized using a single time constant, as were openings within bursts of large amplitude events. When the ACh concentration was increased to 30 μM, durations of individual openings of LS-isoform α4(R336H)β2-nAChR within small (B) or large amplitude (B’) bursts each remained associated with single time constants. Histogram panels each show pooled data, which were collected from 5 or 8 individual patches, across at least three separate experiments. The calculated τ values are summarized as mean ± SEM in Table 6, together with the statistical analyses applied.
	Fig 8. Durations of individual openings within bursts of small or large amplitude openings of human LS-isoform α4β2(V337G)-nAChR.LS-isoform α4β2(V337G)-nAChR were expressed in Xenopus laevis oocytes and durations of individual openings within bursts of activity (intraburst openings) were measured. When LS-isoform α4β2(V337G)-nAChR were stimulated with a low ACh concentration (0.7 μM), bursts of either small (A) or large (A’) amplitude events were seen. The open durations for individual events within bursts of small amplitude openings were best fit with two time constants (τ1 and τ2), while individual openings within bursts of large amplitude events were best fit with a single time constant. When the ACh concentration was increased to 30 μM, intraburst open durations of individual small amplitude openings of LS-isoform α4β2(V337G) nAChR within bursts (B) were best characterized using a single time constant. This contrasts with the two distinct time constants measured for small amplitude openings at the low ACh concentration. Individual open durations of large amplitude events within bursts remained best described with a single time constant, in the presence of the high ACh concentration (B’). Histogram panels each show pooled data, which were collected from 5 or 7 individual patches, across at least three separate experiments. The calculated τ values are summarized as mean ± SEM in Table 6, together with the statistical analyses applied.
	Fig 9. Human LS-isoform α4(R336H)β2-nAChR small and large amplitude burst properties.LS-isoform α4(R336H)β2-nAChR were expressed in Xenopus laevis oocytes. Function was evoked using 0.7 or 30 μM ACh and properties of the resulting bursts of open events were measured. (A) The proportions of small or large amplitude openings falling within bursts (as a fraction of the total numbers of each type of open event) were determined. (B) The mean number of openings per burst of LS-isoform α4(R336H)β2-nAChR was determined. (C) The durations of LS-isoform α4(R336H)β2-nAChR small or large amplitude bursts were measured at the low (0.7 μM) and high (30 μM) ACh concentrations. Noted statistical differences refer to the difference between the receptor property measured for LS-isoform α4(R336H)β2-nAChR versus its wildtype counterpart (i.e. fold change). (D) The Popen within bursts was also measured for bursts of small or large amplitude openings evoked from LS-isoform α4(R336H)β2-nAChR in the presence of the low or high ACh concentrations. Histograms within each panel show pooled data which were collected from 5 or 8 individual patches, respectively, across at least three separate experiments. Values and error bars represent the mean ± SEM of values across patches, and are summarized in Table 7, along with the statistical analyses applied.
	Fig 10. Human LS-isoform α4β2(V337G)-nAChR burst properties.LS-isoform α4β2(V337G)-nAChR were expressed in Xenopus laevis oocytes. Function was evoked using 0.7 or 30 μM ACh, and properties of the resulting bursts of open events were measured. (A) The proportions of small or large amplitude openings falling within bursts (as a fraction of the total numbers of each type of open event) were determined. Noted statistical difference refers to the difference between the receptor property measured for the LS-isoform α4β2(V337G)-nAChR versus its wildtype counterpart. (B) The mean number of openings per burst of LS-isoform α4β2(V337G)-nAChR were measured at each of the two ACh concentrations, for bursts of small or large amplitude openings. (C) The durations of LS-isoform α4β2(V337G)-nAChR small or large amplitude bursts were measured at the low (0.7 μM) and high (30 μM) ACh concentrations. (D) The Popen within bursts was also measured for bursts of small or large amplitude openings evoked from LS-isoform α4β2(V337G)-nAChR in the presence of the low or high ACh concentrations. Histograms within each panel show pooled data, which were collected from 5 and 7 individual patches respectively, across at least three separate experiments. Values and error bars represent the mean ± SEM of values across patches, and are summarized in Table 8, along with the statistical analyses applied.
	Fig 11. Illustration of the α4(R336H)β2- and α4β2(V337G)-nAChR SHE-associated mutant locations substituted into the known cryo-EM structures of 5-HT3AR apo and conducting states.(A) Sequence alignments of 5-HT3AR and nAChR subunits are displayed with numbering based on a start at the translation initiation methionine. The locations of the intracellular loop SHE-associated mutations are highlighted. The α4(R336H) mutation (green) is located in the initial portion of the M3-M4 loop, whereas the β2(V337G) mutation (magenta) is located in the MX helix. (B) Schematic of the major structural domains of a single nAChR subunit. The large extracellular N-terminal agonist-binding domain is followed by four transmembrane helices (M1–M4). The major intracellular domain is located between the M3 and M4 helices and consists of a short initial portion of sequence that connects the M3 helix to the MX helix, the MX helix itself, an extended region of undefined structure, followed by the final M4 transmembrane helix. The locations of both SHE-associated mutations are shown in the initial portion of the M3-M4 domain and the MX helix subdomain of the major intracellular domain, along with that of a likely interacting residue in the MA helix (β2E449; orange, putative interaction denoted with a dotted blue line). Note that β2E449 is not shown in Panel A since it is located far in the linear sequence from the MX helix. (C) The apo (non-ligand-bound; PDB ID: 6BE1) state of the recent cryo-EM structure of the 5-HT3AR [45] was used as the basis to illustrate the locations of the α4(R336H)β2- and α4β2(V337G)-nAChR mutations, since equivalent structural information is not yet available for these intracellular regions of α4β2-nAChR. Position numbers refer to those of the human α4 or β2 nAChR subunit, as shown in the accompanying sequence alignment. Left Panel depicts the positioning of wildtype nAChR α4(R336) and β2(V337) residues, substituted into the known 5-HT3AR structure. The location of the initial portion of the M3-M4 domain, followed by the MX, MA, and M4 helices are labeled. Right Panel illustrates the locations of the SHE-associated α4(R336H) and β2(V337G) residues in the same context. Also shown in both panels is the location of the β2E449 residue thought to interact with α4(R336). (D) Same as (C), except that the residues of interest are substituted into the conducting (ligand-bound; PDB ID: 6DG8) 5-HT3AR cryo-EM structure [31]. Note the upward movement of the MX helix in the conducting, compared to apo, state.

Basak, Cryo-EM reveals two distinct serotonin-bound conformations of full-length 5-HT3A receptor. 2018, Pubmed, Xenbase

Basak, Cryo-EM reveals two distinct serotonin-bound conformations of full-length 5-HT3A receptor. 2018, Pubmed , Xenbase
Basak, Cryo-EM structure of 5-HT3A receptor in its resting conformation. 2018, Pubmed , Xenbase
Bertrand, The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits. 2005, Pubmed
Bouzat, Modulation of muscle nicotinic acetylcholine receptors by the glucocorticoid hydrocortisone. Possible allosteric mechanism of channel blockade. 1996, Pubmed
Briggs, High- and low-sensitivity subforms of alpha4beta2 and alpha3beta2 nAChRs. 2006, Pubmed
Carignano, Analysis of neuronal nicotinic acetylcholine receptor α4β2 activation at the single-channel level. 2016, Pubmed
Chen, A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy. 2009, Pubmed
Colquhoun, Fluctuations in the microsecond time range of the current through single acetylcholine receptor ion channels. 1981, Pubmed
De Fusco, The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. 2000, Pubmed
Eaton, The unique α4+/-α4 agonist binding site in (α4)3(β2)2 subtype nicotinic acetylcholine receptors permits differential agonist desensitization pharmacology versus the (α4)2(β2)3 subtype. 2014, Pubmed , Xenbase
Gharpure, Agonist Selectivity and Ion Permeation in the α3β4 Ganglionic Nicotinic Receptor. 2019, Pubmed
Grosman, The dissociation of acetylcholine from open nicotinic receptor channels. 2001, Pubmed
Hales, Common determinants of single channel conductance within the large cytoplasmic loop of 5-hydroxytryptamine type 3 and alpha4beta2 nicotinic acetylcholine receptors. 2006, Pubmed
Hirose, A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. 1999, Pubmed
Hoskin, Nicotinic Acetylcholine Receptor Agonists for the Treatment of Alzheimer's Dementia: An Update. 2019, Pubmed
Indurthi, Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry. 2019, Pubmed , Xenbase
Jackson, Successive openings of the same acetylcholine receptor channel are correlated in open time. 1983, Pubmed
Jadey, An integrated catch-and-hold mechanism activates nicotinic acetylcholine receptors. 2012, Pubmed
KATZ, A study of the desensitization produced by acetylcholine at the motor end-plate. 1957, Pubmed
Kracun, Influence of the M3-M4 intracellular domain upon nicotinic acetylcholine receptor assembly, targeting and function. 2008, Pubmed
Kullmann, Genetics of epilepsy. 2002, Pubmed
Kuo, Roles for nicotinic acetylcholine receptor subunit large cytoplasmic loop sequences in receptor expression and function. 2005, Pubmed
Lassi, The CHRNA5-A3-B4 Gene Cluster and Smoking: From Discovery to Therapeutics. 2016, Pubmed
Liu, The identification of a novel mutation of nicotinic acetylcholine receptor gene CHRNB2 in a Chinese patient: Its possible implication in non-familial nocturnal frontal lobe epilepsy. 2011, Pubmed
Liu, Insights Into Nicotinic Receptor Signaling in Nicotine Addiction: Implications for Prevention and Treatment. 2018, Pubmed
Lukas, International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. 1999, Pubmed
Marks, Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit. 1999, Pubmed
Mazzaferro, Additional acetylcholine (ACh) binding site at alpha4/alpha4 interface of (alpha4beta2)2alpha4 nicotinic receptor influences agonist sensitivity. 2011, Pubmed , Xenbase
Mazzaferro, α4β2 Nicotinic Acetylcholine Receptors: RELATIONSHIPS BETWEEN SUBUNIT STOICHIOMETRY AND FUNCTION AT THE SINGLE CHANNEL LEVEL. 2017, Pubmed
Militante, Activation and block of the adult muscle-type nicotinic receptor by physostigmine: single-channel studies. 2008, Pubmed
Moroni, Stoichiometry and pharmacology of two human alpha4beta2 nicotinic receptor types. 2006, Pubmed , Xenbase
Mortensen, Single-channel recording of ligand-gated ion channels. 2007, Pubmed
Motamedi, Autosomal dominant nocturnal frontal lobe epilepsy. 2002, Pubmed
Nelson, Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors. 2003, Pubmed , Xenbase
Newport, The MemProtMD database: a resource for membrane-embedded protein structures and their lipid interactions. 2019, Pubmed
Papke, Mechanisms of noncompetitive inhibition of acetylcholine-induced single-channel currents. 1989, Pubmed
Provini, Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases. 1999, Pubmed
Qin, Estimating single-channel kinetic parameters from idealized patch-clamp data containing missed events. 1996, Pubmed , Xenbase
Qin, Restoration of single-channel currents using the segmental k-means method based on hidden Markov modeling. 2004, Pubmed
Qin, Maximum likelihood estimation of aggregated Markov processes. 1997, Pubmed
Quik, Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders. 2019, Pubmed
Sakmann, Single acetylcholine-activated channels show burst-kinetics in presence of desensitizing concentrations of agonist. 1980, Pubmed
Scheffer, Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder. 1994, Pubmed
Sine, Activation of a nicotinic acetylcholine receptor. 1984, Pubmed
Steinlein, A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. 1995, Pubmed
Steinlein, Genetic mechanisms that underlie epilepsy. 2004, Pubmed
Steinlein, Animal models for autosomal dominant frontal lobe epilepsy: on the origin of seizures. 2010, Pubmed , Xenbase
Steinlein, An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. 1997, Pubmed
Tapia, Ca2+ permeability of the (alpha4)3(beta2)2 stoichiometry greatly exceeds that of (alpha4)2(beta2)3 human acetylcholine receptors. 2007, Pubmed , Xenbase
Tinuper, Definition and diagnostic criteria of sleep-related hypermotor epilepsy. 2016, Pubmed
Utkin, Aging Affects Nicotinic Acetylcholine Receptors in Brain. 2019, Pubmed
Walsh, Structural principles of distinct assemblies of the human α4β2 nicotinic receptor. 2018, Pubmed
Weltzin, Distinctive single-channel properties of α4β2-nicotinic acetylcholine receptor isoforms. 2019, Pubmed , Xenbase
Weltzin, Distinctive effects of nicotinic receptor intracellular-loop mutations associated with nocturnal frontal lobe epilepsy. 2016, Pubmed , Xenbase
Wu, Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors. 2006, Pubmed
Zoli, Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors. 2018, Pubmed